(Q40498246)

English

Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Orthonairovirus haemorrhagiae

0 references

Rift Valley fever phlebovirus

0 references

Hantaan River virus

1 reference

based on heuristic

inferred from title

Rift Valley fever

1 reference

based on heuristic

inferred from title

tick-borne encephalitis

1 reference

based on heuristic

inferred from title

tick-borne encephalitis virus

object named as

tick-borne encephalitis virus

1 reference

based on heuristic

inferred from title

Rift Valley fever virus

object named as

Rift Valley fever virus

1 reference

based on heuristic

inferred from title

object named as

Anita K McElroy

3

0 references

object named as

Jay W Hooper

5

0 references

author name string

Kristin Spik

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Amy Shurtleff

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Mary C Guttieri

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Connie SchmalJohn

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

22 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4657-4666

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Hantaviruses: A Global Disease Problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

More deaths from Rift Valley fever in Saudi Arabia and Yemen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Evaluation of tick-borne encephalitis DNA vaccines in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Hantaan virus infection in suckling mice: virologic and pathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Multivalent DNA-based immunization against hepatitis B virus with plasmids encoding surface and core antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.08.034

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40498246&oldid=1899383699"